# Dropless Pars Plana Vitrectomy Study

> **NCT05331664** · PHASE4 · RECRUITING · sponsor: **Massachusetts Eye and Ear Infirmary** · enrollment: 168 (estimated)

## Conditions studied

- Rhegmatogenous Retinal Detachment

## Interventions

- **PROCEDURE:** Pars plana vitrectomy
- **DRUG:** Triamcinolone Acetonide 40mg/mL
- **DRUG:** Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin
- **DRUG:** Prednisolone 1%
- **DRUG:** Atropine 1%

## Key facts

- **NCT ID:** NCT05331664
- **Lead sponsor:** Massachusetts Eye and Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-25
- **Primary completion:** 2026-07-25
- **Final completion:** 2027-01-30
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05331664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05331664, "Dropless Pars Plana Vitrectomy Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05331664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*